Home/Filings/4/0001209191-09-016039
4//SEC Filing

Mengler Christopher 4

Accession 0001209191-09-016039

CIK 0001003642other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 12:33 PM ET

Size

9.4 KB

Accession

0001209191-09-016039

Insider Transaction Report

Form 4
Period: 2009-03-05
Mengler Christopher
President, Global Pharm. Div.
Transactions
  • Purchase

    Common Stock

    2009-03-12$5.50/sh+5,000$27,50045,000 total
  • Award

    Common Stock

    2009-03-05+30,00040,000 total
  • Award

    Employee Stock Option (Right to Buy)

    2009-03-05+75,00075,000 total
    Exercise: $6.00Exp: 2019-03-05Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]The option becomes exercisable in four equal annual installments beginning on March 5, 2010, which is the first anniversary of the date on which the option was granted.

Issuer

IMPAX LABORATORIES INC

CIK 0001003642

Entity typeother

Related Parties

1
  • filerCIK 0001336015

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 12:33 PM ET
Size
9.4 KB